Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544865 · ClinicalTrials.gov registry record · NA
Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement
A NA study of Gastric Procedures and Lung Resection Procedures, sponsored by Ethicon Endo-Surgery.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 8
- Study locations
NCT04544865 is a NA study of Gastric Procedures and Lung Resection Procedures that has completed, run by Ethicon Endo-Surgery. The registered enrollment target is 240 participants. The trial reports 8 study locations across 7 states.
The verdict
NCT04544865, a NA study of Gastric Procedures and Lung Resection Procedures, has completed, sponsored by Ethicon Endo-Surgery.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 8
- Study locations
Study Summary
This prospective, single-arm, multi-center evaluation will collect clinical data in a post-market setting. The two types of procedures studied will be gastric and thoracic. Investigators will perform each procedure using the device in compliance with their standard surgical approach and the ECHELON ENDOPATH Staple Line Reinforcement instructions for use.
Conditions Studied
Interventions
- DEVICE Staple Line Reinforcement
Study Locations (8)
Michigan
- Henry Ford Health System - Detroit
- Spectrum Health - Grand Rapids
Indiana
- Indiana University Health - Indianapolis
Louisiana
- Our Lady of the Lake Regional Medical Center - Baton Rouge
Missouri
- University of Missouri - Columbia
New York
- Long Island Jewish Medical Center - New York
North Carolina
- Atrium Health - Charlotte
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2020-09-29 |
| Est. Completion | 2023-02-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04544865
The ClinicalTrials.gov registry entry for NCT04544865 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ethicon Endo-Surgery, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gastric Procedures appearing as the primary indexed condition, and to 1 intervention - of which Staple Line Reinforcement is the first listed.
NCT04544865 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Michigan, Indiana, Louisiana.
Frequently Asked Questions
What is clinical trial NCT04544865 about?
NCT04544865 is a clinical study titled "Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement". This prospective, single-arm, multi-center evaluation will collect clinical data in a post-market setting. The two types of procedures studied will be gastric and thoracic. Investigators will perform each procedure using the device in compliance with their standard surgical approach and the ECHELON ...
What is the current status of trial NCT04544865?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2020-09-29. Estimated completion is 2023-02-08.
What conditions does trial NCT04544865 study?
This clinical trial studies the following conditions: Gastric Procedures, Lung Resection Procedures.
What interventions are being tested in trial NCT04544865?
The interventions under investigation include: Staple Line Reinforcement (DEVICE).
Who is sponsoring clinical trial NCT04544865?
This trial is sponsored by Ethicon Endo-Surgery, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04544865 being conducted?
This trial has 8 study locations across Indiana, Louisiana, Michigan, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.